Valuation: Biodesix, Inc.

Market Cap 209M 187M 171M 155M 293M 19.78B 301M 2.05B 820M 10.48B 786M 769M 33.06B P/E 2026 *
-7.43x
P/E 2027 * -11.9x
Enterprise Value 209M 187M 171M 155M 293M 19.78B 301M 2.05B 820M 10.48B 786M 769M 33.06B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.55x
Free-Float
54.93%
Yield 2026 *
-
Yield 2027 * -
1 day-31.45%
1 week-19.74%
Current month-14.69%
1 month-31.73%
3 months-12.91%
6 months+32.80%
Current year+191.76%
1 week 19.07
Extreme 19.067046
23.31
1 month 19.07
Extreme 19.067046
27.78
Current year 5.26
Extreme 5.26
31.97
1 year 5.26
Extreme 5.26
31.97
3 years 3.44
Extreme 3.436
44.2
5 years 3.44
Extreme 3.436
166.87
10 years 3.44
Extreme 3.436
639.8
Manager TitleAgeSince
Chief Executive Officer 54 01/01/2020
Director of Finance/CFO 46 01/04/2017
Chief Tech/Sci/R&D Officer - 01/01/2016
Director TitleAgeSince
Chairman 79 14/09/2020
Director/Board Member 53 01/01/2012
Director/Board Member 59 01/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Exercice

Chairman

2,720 0.0340%
12/08/26 Buy 15,000 0.1422%
11/08/26 Buy 13,700 0.1298%
Change 5-day change 1-year change 3-year change Capi.($)
-7.68%-19.74%+130.70%-38.00% 209M
-0.63%+6.15%+7.24%+119.84% 106B
+1.71%-9.96%+3.54%+15.77% 104B
-6.97%-16.57%+81.95%+751.10% 52.43B
+9.44%0.00%-2.19%+85.70% 32.79B
-1.22%-1.32%+44.92%+72.82% 29.5B
-0.37%+0.72%+42.90%+90.23% 28.03B
-1.98%+5.87%+37.31%+421.60% 22.8B
+1.12%-2.57%-19.05%-14.02% 20.12B
-0.26%-1.91%-6.33%+28.12% 16.86B
Average -4.15%-3.71%+32.10%+153.32% 41.28B
Weighted average by Cap. -1.76%-2.81%+20.05%+172.02%

Financials

2026 *2027 *
Net sales 112M 99.64M 91.14M 83M 156M 10.57B 161M 1.09B 438M 5.6B 420M 411M 17.66B 135M 120M 110M 99.93M 188M 12.72B 193M 1.32B 527M 6.74B 505M 494M 21.26B
Net income -27.51M -24.52M -22.42M -20.42M -38.49M -2.6B -39.53M -269M -108M -1.38B -103M -101M -4.34B -19.47M -17.35M -15.87M -14.45M -27.25M -1.84B -27.98M -191M -76.25M -975M -73.09M -71.52M -3.08B
Net Debt - -
Projected Income Statement - Annual - Biodesix, Inc.
Logo Biodesix, Inc.
Biodesix, Inc. is a diagnostic solutions company. The Company's business includes Biodesix Lung Diagnostic Testing and Biodesix Development Services. Its Biodesix Lung Diagnostic Testing provides lung diagnostic testing services for healthcare providers through five blood-based tests. Its Biodesix Development Services supports global biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that enable the development of diagnostic tests, tools, and therapeutics. The Company offers Nodify Lung tests and IQLung tests that assess cancer risk and provide treatment guidance following a lung cancer diagnosis. The Nodify Lung tests include Nodify CDT and Nodify XL2 tests, which evaluate the risk of lung cancer in lung nodules. The GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests are used in the diagnosis of lung cancer to detect tumor mutations and assess the patient’s immune system status.
Employees
334
Date Price Change Volume
05/11/26 $19.84 -7.68% 186,118
04/11/26 $21.49 +2.09% 148,065
03/11/26 $21.05 -3.35% 38,787
02/11/26 $21.78 -6.34% 75,630
30/10/26 $23.26 -5.93% 67,248
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Biodesix, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.84USD
Average target price
39.00USD
Spread / Average Target
+96.57%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biodesix, Inc.
  1. Stock Market
  2. Stocks
  3. BDSX Stock